3 Heart Disease Focused Stocks To Buy Ahead Of World Heart Day

With World Heart Day coming up, let’s take a look at some well-positioned stocks in this segment of the market.  

BioTelemetry, Inc. (BEAT - Free Report) : Malvern, PA-based BioTelemetry is a wireless medical technology company which provides health information with the aim of improving the quality of life and reduce the cost of care. The company provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized core laboratory services.

The Zacks Rank #2 (Buy) stock has a strong earnings track record having surpassed expectations in each of the last four quarters. The recent acquisition of LifeWatch has positioned the company as the largest provider of remote healthcare services in the world. BioTelemetry looks well-positioned in the rapidly evolving connected health market and expects to serve more than a million patients in 2018.

Shares of BioTelemetry have gained 39.8% year to date, significantly outperforming the industry’s 4% rally.

(Click on image to enlarge)

Edwards Lifesciences Corp. (EW - Free Report) : Edwards Lifesciences holds a leading position in patient-focused innovations for structural heart disease and critical care monitoring. The company’s portfolio includes products like annuloplasty rings, catheters and heart valves that enable the treatment of patients with cardiovascular disease. Edwards Lifesciences is focused on developing transformational structural heart therapies and estimates that the global transcatheter aortic valve replacement (TAVR) opportunity could cross $5 billion by 2021 driven by increasing awareness, expanding indications and improving technology. Shares of this Zacks Rank #1 (Strong Buy) stock, which holds a strong position in the approximately $1.8 billion global surgical heart valve segment, are up 17.9% year to date compared to the industry’s rally of 17.8%. The company has consistently surpassed earnings expectations in each of the last four quarters. 

View single page >> |

Disclosure: Zacks.com contains statements and statistics that have been obtained from sources believed to be reliable but are not guaranteed as to accuracy or completeness. References to any ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.